HOME >> BIOLOGY >> NEWS
Other highlights in the Jan. 16 issue of JNCI

DNA Repair Capability May Influence Likelihood of Developing Melanoma
A new study suggests that the bodys ability to repair DNA damage caused by ultraviolet radiation from sunlight may influence the risk of melanoma in people who do not tan easily and who have many unusually large and irregularly shaped moles (called dysplastic nevi).

Dysplastic nevi and low tanning ability are known risk factors for melanoma. Exposure to UV radiation from sunlight is also associated with an increased risk of the disease. Maria Teresa Landi, M.D., Ph.D., of the National Cancer Institute, and colleagues looked at a group of patients in Italy to determine whether the cellular capacity to repair DNA damage is associated with the risk of cutaneous malignant melanoma.

By studying 132 patients with melanoma and 145 control subjects, the authors found that, independent of other risk factors, DNA repair capacity was not associated with an increased risk of melanoma. However, among patients who had low tanning ability or dysplastic nevi, those with a low DNA repair capacity had a higher risk of the disease than those with a high DNA repair capacity. These results are presented in the Jan. 16 issue of the Journal of the National Cancer Institute.

Contact: NCI Press Office, (301) 496-6641

Predictive Value of HPV Testing in Managing Equivocal Pap Tests Improves with Age, Study Shows
Each year, about 50 million Pap tests are taken in the United States, 2 million of which are not entirely normal. Most Pap tests that are not clearly normal show equivocal (aytpical squamous cells of undetermined significance [ASCUS]) or mild (low-grade squamous intraepithelial lesions [LSIL]) abnormalities.

Only about 5% of women with ASCUS and 10% of those with LSIL have a known precursor to cancer, called cervical intraepithelial neoplasia 3 (CIN3). Therefore, referring all women with ASCUS or LSIL for colposcopy (examination of the cervix
'"/>

Contact: Linda Wang
jncinews@oup-usa.org
301-594-2927
Journal of the National Cancer Institute
15-Jan-2002


Page: 1 2 3 4

Related biology news :

1. Other highlights in the September 1 JNCI
2. Other highlights in the August 18 JNCI
3. Other highlights in the August 4 JNCI
4. Other highlights in the July 7 JNCI
5. Other highlights in the June 16 JNCI
6. Other Highlights in the June 2 JNCI
7. Other highlights in the May 19 JNCI
8. Other highlights in the May 5 JNCI
9. Other highlights of the March 17 issue of JNCI
10. Other highlights in the March 3 issue of JNCI
11. Other highlights in the February 18 issue of JNCI

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Other highlights the Jan issue JNCI

(Date:2/5/2015)... Epic Sciences , a precision diagnostics company dedicated to improving ... , Ph.D., president and CEO, is scheduled to present at ... Valley, which is taking place at the Computer History Museum ... 26-28, 2015. Dr. Prahalad will give a ... Epic Sciences was a finalist in the PMWC,s Most Promising ...
(Date:2/5/2015)... -- New Market Research Reports Title Global ... 2020 has Been Added to GrandViewReseach.com Report Database ... reach USD 5.10 billion by 2020, according to a ... help identify the site of tissue damage in case ... in medical imaging applications. They have been extensively used ...
(Date:2/5/2015)... JOLLA, Calif. , Jan. 30, 2015  It ... the great power and potential for genomic science as ... aid in disease prevention and treatment.  I was honored ... potential new, government-funded precision medicine program. ... advancing the science of genomics—from the first sequenced genome ...
Breaking Biology News(10 mins):Epic Sciences to Present at Personalized Medicine World Conference 2015 on the Use of Circulating Tumor Cells as Cancer Biomarkers 2IR Camera Market Worth $5.10 Billion By 2020: Grand View Research, Inc. 2IR Camera Market Worth $5.10 Billion By 2020: Grand View Research, Inc. 3J. Craig Venter, Ph.D., Co-Founder and CEO, Human Longevity, Inc. (HLI) Participates in White House Precision Medicine Event 2
(Date:2/26/2015)... 2015 On behalf of biotech client ... Wilentz, Goldman & Spitzer, P.A. (Wilentz) secured ... against Genewiz Inc. in excess of $10 million. The ... trade secrets, and that it improperly hired one or ... order denying motions for judgment notwithstanding the verdict, a ...
(Date:2/26/2015)... Calif. , Feb. 26, 2015 The healthcare ... this ever-changing arena, Frost & Sullivan will host its ... Sullivan Executive MindXchange , March 8 to 10, at the ... Diego, Calif. This event is a ... healthcare leaders to discuss industry disruptions and how to succeed ...
(Date:2/26/2015)... The Pittcon 2015 Exposition, which takes ... Morial Convention Center in New Orleans, Louisiana, will ... 2015) displaying products and services used by the ... The Exposition will offer the latest innovations in ... chemistry; drug discovery; nanotechnology; life sciences to include ...
(Date:2/26/2015)... February 26, 2015 Innovation is ... emerging from unexpected parts of the world and ... From agriculture to manufacturing to health care, disruption ... environmental realities and socio-political trends shake the foundations ... key ingredient for CEOs to survive the next ...
Breaking Biology Technology:Wilentz Client GenScript Awarded $10 Million in Trade Secrets Case Against Genewiz 2Wilentz Client GenScript Awarded $10 Million in Trade Secrets Case Against Genewiz 3Embrace the Future of Medical Technologies with Frost & Sullivan 2Embrace the Future of Medical Technologies with Frost & Sullivan 3Pittcon 2015 Announces Exposition Highlights 2One Million Acts of Innovation Canada Creates Partnership with The Economist Events’ Innovation Forum 2
Cached News: